Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings
Abstract
:1. Introduction
2. Candida auris Identification
3. Candida auris Antifungal Susceptibility Testing
4. Infection Control Practices
- Clinically indicated.
- C. auris has been detected in the facility or unit.
- A patient has had an overnight stay in a healthcare facility outside the United States in the preceding year, especially if that stay was in a country with documented C. auris transmission.
5. Treatment and Management of Infections and Colonization
6. Communication
7. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
Disclaimer
References
- Cortegiani, A.; Misseri, G.; Fasciana, T.; Giammanco, A.; Giarratano, A.; Chowdhary, A. Epidemiology, clinical characteristics, resistance, and treatment of infections by Candida auris. J. Intensive Care 2018, 6, 69. [Google Scholar] [CrossRef] [PubMed]
- Meis, J.F.; Chowdhary, A. Candida auris: A global fungal public health threat. Lancet Infect Dis. 2018, 18, 1298–1299. [Google Scholar] [CrossRef]
- Forsberg, K.; Woodworth, K.; Walters, M.; Berkow, E.L.; Jackson, B.; Chiller, T.; Vallabhaneni, S. Candida auris: The recent emergence of a multidrug-resistant fungal pathogen. Med Mycol. 2018, 57, 1–12. [Google Scholar] [CrossRef] [PubMed]
- Osei Sekyere, J. Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen. MicrobiologyOpen 2018, 7, e00578. [Google Scholar] [CrossRef] [PubMed]
- Recommendations for Identification of Candida auris. 2018. Available online: https://www.cdc.gov/fungal/candida-auris/recommendations.html (accessed on 22 October 2019).
- Kathuria, S.; Singh, P.K.; Sharma, C.; Prakash, A.; Masih, A.; Kumar, A.; Meis, J.F.; Chowdhary, A. Multidrug-resistant Candida auris misidentified as Candida haemulonii: Characterization by matrix-assisted laser desorption ionization-time of flight mass spectrometry and DNA sequencing and its antifungal susceptibility profile variability by Vitek 2, CLSI broth microdilution, and Etest method. J. Clin. Microbiol. 2015, 53, 1823–1830. [Google Scholar] [PubMed]
- Welsh, R.M.; Bentz, M.L.; Shams, A.; Houston, H.; Lyons, A.; Rose, L.J.; Litvintseva, A.P. Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Health Care Surface. J. Clin. Microbiol. 2017, 55, 2996–3005. [Google Scholar] [CrossRef] [PubMed]
- Salt Sabouraud Dulcitol Broth (SSDB). 2018. Available online: https://s2cm.com/product/salt-sabouraud-dulcitol-broth-ssdb/ (accessed on 22 October 2019).
- Kumar, A.; Sachu, A.; Mohan, K.; Vinod, V.; Dinesh, K.; Karim, S. Simple low cost differentiation of Candida auris from Candida haemulonii complex using CHROMagar Candida medium supplemented with Pal’s medium. Rev. Iberoam. Micol. 2017, 34, 109–111. [Google Scholar] [CrossRef]
- Mizusawa, M.; Miller, H.; Green, R.; Lee, R.; Durante, M.; Perkins, R.; Hewitt, C.; Simner, P.J.; Carroll, K.C.; Hayden, R.T.; et al. Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories? J. Clin. Microbiol. 2017, 55, 638–640. [Google Scholar] [CrossRef]
- Voelker, R. New Test Identifies Candida auris. Jama 2018, 319, 2164. [Google Scholar] [CrossRef]
- Lockhart, S.R.; Berkow, E.L.; Chow, N.; Welsh, R.M. Candida auris for the clinical microbiology laboratory: Not your grandfather’s Candida species. Clin. Microbiol. Newsl. 2017, 39, 99–103. [Google Scholar] [CrossRef]
- Lockhart, S.R.; Etienne, K.A.; Vallabhaneni, S.; Farooqi, J.; Chowdhary, A.; Govender, N.P.; Colombo, A.L.; Calvo, B.; Cuomo, C.A.; Desjardins, C.A.; et al. Simultaneous emergence of multidrug-resistant Candida auris on 3 continents confirmed by whole-genome sequencing and epidemiological analyses. Clin. Infect. Dis. 2017, 64, 134–140. [Google Scholar] [CrossRef] [PubMed]
- Lockhart, S.R.; Jackson, B.R.; Vallabhaneni, S.; Ostrosky-Zeichner, L.; Pappas, P.G.; Chiller, T. Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris. J. Clin. Microbiol. 2017, 55, 3324–3327. [Google Scholar] [CrossRef] [PubMed]
- Ambaraghassi, G.; Dufresne, P.J.; Dufresne, S.F.; Vallieres, E.; Munoz, J.F.; Cuomo, C.A.; Berkow, E.L.; Lockhart, S.R.; Luong, M.L. Identification of Candida auris using the updated 8.01 VITEK2 yeast identification system: A multi-laboratory evaluation study. J. Clin. Microbiol. 2019, 57, e00884-19. [Google Scholar] [CrossRef] [PubMed]
- Cendejas-Bueno, E.; Kolecka, A.; Alastruey-Izquierdo, A.; Theelen, B.; Groenewald, M.; Kostrzewa, M.; Cuenca-Estrella, M.; Gómez-López, A.; Boekhout, T. Reclassification of the Candida haemulonii complex as Candida haemulonii (C. haemulonii group I.), C. duobushaemulonii sp. nov. (C. haemulonii group II), and C. haemulonii var. vulnera var. nov.: Three multiresistant human pathogenic yeasts. J. Clin. Microbiol. 2012, 50, 3641–3651. [Google Scholar] [CrossRef]
- Sharp, A.; Borman, A.M.; Perera, N.; Randle, M.; Braham, S.; Taori, S.; Charlett, A.; Guy, R.; Muller-Pebody, B.; Manuel, R.; et al. Assessing routine diagnostic methods for detecting Candida auris in England. J. Infect. 2018, 77, 448–454. [Google Scholar] [CrossRef]
- Durante, A.J.; Maloney, M.H.; Leung, V.H.; Razeq, J.H.; Banach, D.B. Challenges in identifying Candida auris in hospital clinical laboratories: A need for hospital and public health laboratory collaboration in rapid identification of an emerging pathogen. Infect. Control Hosp. Epidemiol. 2018, 39, 1015–1016. [Google Scholar] [CrossRef]
- Leach, L.; Zhu, Y.; Chaturvedi, S. Development and Validation of a Real-Time PCR Assay for Rapid Detection of Candida auris from Surveillance Samples. J. Clin. Microbiol. 2018, 56, e01223-17. [Google Scholar] [CrossRef]
- Ahmad, A.; Spencer, J.E.; Lockhart, S.R.; Singleton, S.; Petway, D.J.; Bagarozzi, D.A., Jr.; Herzegh, O.T. A high-throughput and rapid method for accurate identification of emerging multidrug-resistant Candida auris. Mycoses 2019, 62, 513–518. [Google Scholar] [CrossRef]
- Sexton, D.J.; Kordalewska, M.; Bentz, M.L.; Welsh, R.M.; Perlin, D.S.; Litvintseva, A.P. Direct Detection of Emergent Fungal Pathogen Candida auris in Clinical Skin Swabs by SYBR Green-Based Quantitative PCR Assay. J. Clin. Microbiol. 2018, 56, e01337-18. [Google Scholar] [CrossRef]
- Sexton, D.J.; Bentz, M.L.; Welsh, R.M.; Litvintseva, A.P. Evaluation of a new T2 Magnetic Resonance assay for rapid detection of emergent fungal pathogen Candida auris on clinical skin swab samples. Mycoses 2018, 61, 786–790. [Google Scholar] [CrossRef]
- Martinez-Murcia, A.; Navarro, A.; Bru, G.; Chowdhary, A.; Hagen, F.; Meis, J.F. Internal validation of GPS() MONODOSE CanAur dtec-qPCR kit following the UNE/EN ISO/IEC 17025:2005 for detection of the emerging yeast Candida auris. Mycoses 2018, 61, 877–884. [Google Scholar] [CrossRef]
- Lima, A.; Widen, R.; Vestal, G.; Uy, D.; Silbert, S. A TaqMan Probe-Based Real-Time PCR Assay for the Rapid Identification of the Emerging Multidrug-Resistant Pathogen Candida auris on the BD Max System. J. Clin. Microbiol. 2019, 57, e01604-18. [Google Scholar] [CrossRef] [PubMed]
- BD MAX™ System. 2019. Available online: https://moleculardiagnostics.bd.com/bd-max-system/ (accessed on 22 October 2019).
- Fungiplex® Candida IVD PCR: When Time Matters. 2019. Available online: https://www.bruker.com/products/molecular-diagnostics/fungiplex-candida-pcr-kits.html (accessed on 22 October 2019).
- Yamamoto, M.; Alshahni, M.M.; Tamura, T.; Satoh, K.; Iguchi, S.; Kikuchi, K.; Mimaki, M.; Makimura, K. Rapid Detection of Candida auris Based on Loop-Mediated Isothermal Amplification (LAMP). J. Clin. Microbiol. 2018, 56. [Google Scholar] [CrossRef]
- Arastehfar, A.; Fang, W.; Badali, H.; Vaezi, A.; Jiang, W.; Liao, W.; Pan, W.; Hagen, F.; Boekhout, T. Low-Cost Tetraplex PCR for the Global Spreading Multi-Drug Resistant Fungus, Candida auris and Its Phylogenetic Relatives. Front. Microbiol. 2018, 9, 1119. [Google Scholar] [CrossRef] [PubMed]
- Arastehfar, A.; Fang, W.; Daneshnia, F.; Al-Hatmi, A.M.; Liao, W.; Pan, W.; Khan, Z.; Ahmad, S.; Rosam, K.; Lackner, M.; et al. Novel multiplex real-time quantitative PCR detecting system approach for direct detection of Candida auris and its relatives in spiked serum samples. Future Microbiol. 2019, 14, 33–45. [Google Scholar] [CrossRef]
- Theill, L.; Dudiuk, C.; Morales-Lopez, S.; Berrio, I.; Rodriguez, J.Y.; Marin, A.; Gamarra, S.; Garcia-Effron, G. Single-tube classical PCR for Candida auris and Candida haemulonii identification. Rev. Iberoam. Micol. 2018, 35, 110–112. [Google Scholar] [CrossRef]
- Blood Culture Identification (BCID) Panels. 2019. Available online: https://www.genmarkdx.com/solutions/panels/eplex-panels/blood-culture-identification-panels/ (accessed on 22 October 2019).
- Clinical Alert to U.S. Healthcare Facilities. 2016. Available online: https://www.cdc.gov/fungal/diseases/candidiasis/candida-auris-alert.html (accessed on 22 October 2019).
- Brotes de ‘Candida auris’ en Servicios de Atención a la Salud. 2016. Available online: http://www.paho.org/hq/index.php?option=com_content&view=article&id=12565%3A3-october-2016-candida-auris-outbreaks-in-health-care-services-epidemiological-alert&catid=2103%3Arecent-epidemiological-alerts-updates&Itemid=42346 (accessed on 22 October 2019).
- Candida auris in Healthcare Settings. 2016. Available online: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Candida-in-healthcare-settings_19-Dec-2016.pdf (accessed on 22 October 2019).
- Arauz, A.B.; Caceres, D.H.; Santiago, E.; Armstrong, P.; Arosemena, S.; Ramos, C.; Espinosa-Bode, A.; Borace, J.; Hayer, L.; Cedeño, I.; et al. Isolation of Candida auris from 9 patients in Central America: Importance of accurate diagnosis and susceptibility testing. Mycoses 2018, 61, 44–47. [Google Scholar] [CrossRef] [PubMed]
- Morales-Lopez, S.E.; Parra-Giraldo, C.M.; Ceballos-Garzon, A.; Martinez, H.P.; Rodriguez, G.J.; Alvarez-Moreno, C.A.; Rodríguez, J.Y. Invasive infections with multidrug-resistant yeast Candida auris, Colombia. Emerg. Infect. Dis. 2017, 23, 162–164. [Google Scholar] [CrossRef]
- M60 Performance Standards for Antifungal Susceptibility Testing of Yeasts. 2017. Available online: https://clsi.org/ (accessed on 22 October 2019).
- Lepak, A.J.; Zhao, M.; Berkow, E.L.; Lockhart, S.R.; Andes, D.R. Pharmacodynamic optimization for treatment of invasive Candida auris infection. Antimicrob. Agents Chemother. 2017, 61, e00791-17. [Google Scholar] [CrossRef]
- Edwards, J.E., Jr.; Dolin, R.; Blaser, M.J. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th ed.; Elsevier: Philadelphia, PA, USA, 2015; pp. 2879–2894. [Google Scholar]
- Recommendations for Infection Prevention and Control for Candida auris. 2018. Available online: https://www.cdc.gov/fungal/candida-auris/c-auris-infection-control.html (accessed on 22 October 2019).
- Escandon, P.; Chow, N.A.; Caceres, D.H.; Gade, L.; Berkow, E.L.; Armstrong, P.; Rivera, S.; Misas, E.; Duarte, C.; Moulton-Meissner, H.; et al. Molecular epidemiology of Candida auris in Colombia reveals a highly-related, country-wide colonization with regional patterns in Amphotericin B resistance. Clin. Infect. Dis. 2018, 68, 15–21. [Google Scholar]
- Eyre, D.W.; Sheppard, A.E.; Madder, H.; Moir, I.; Moroney, R.; Quan, T.P.; Griffiths, D.; George, S.; Butcher, L.; Morgan, M.; et al. A Candida auris Outbreak and Its Control in an Intensive Care Setting. N. Engl. J. Med. 2018, 379, 1322–1331. [Google Scholar] [CrossRef]
- Standardized Case Definition for Candida auris Clinical and Colonization/Screening Cases and National Notification of C. auris. 2018. Available online: https://cdn.ymaws.com/www.cste.org/resource/resmgr/ps/2018ps/18-ID-05_Dec2018_Update.pdf (accessed on 22 October 2019).
- Brooks, R.B.; Walters, M.; Forsberg, K.; Vaeth, E.; Woodworth, K.; Vallabhaneni, S. Candida auris in a U.S. Patient with Carbapenemase-Producing Organisms and Recent Hospitalization in Kenya. MMWR Morb. Mortal. Wkly. Rep. 2019, 68, 664–666. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Biswal, M.; Rudramurthy, S.M.; Jain, N.; Shamanth, A.S.; Sharma, D.; Jain, K.; Yaddanapudi, L.N.; Chakrabarti, A. Controlling a possible outbreak of Candida auris infection: Lessons learnt from multiple interventions. J. Hosp. Infect. 2017, 97, 363–370. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Hand Hygiene: Why, How & When? 2009. Available online: http://www.who.int/gpsc/5may/Hand_Hygiene_Why_How_and_When_Brochure.pdf (accessed on 22 October 2019).
- Core Infection Prevention and Control Practices for Safe Healthcare Delivery in All Settings—Recommendations of the HICPAC. 2018. Available online: https://www.cdc.gov/hicpac/pdf/core-practices.pdf (accessed on 22 October 2019).
- Implementation of Personal Protective Equipment (PPE) in Nursing Homes to Prevent Spread of Novel or Targeted Multidrug-resistant Organisms (MDROs). 2019. Available online: https://www.cdc.gov/hai/containment/PPE-Nursing-Homes.html (accessed on 22 October 2019).
- Transmission-Based Precautions. 2017. Available online: https://www.cdc.gov/infectioncontrol/basics/transmission-based-precautions.html (accessed on 22 October 2019).
- Klebsiella pneumoniae in Healthcare Settings. 2012. Available online: https://www.cdc.gov/HAI/organisms/klebsiella/klebsiella.html (accessed on 22 October 2019).
- Facility Guidance for Control of Carbapenem-Resistant Enterobacteriaceae (CRE). 2015. Available online: https://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf (accessed on 22 October 2019).
- Isolation Precautions. 2007. Available online: https://www.cdc.gov/infectioncontrol/guidelines/isolation/index.html (accessed on 22 October 2019).
- Ku, T.S.N.; Walraven, C.J.; Lee, S.A. Candida auris: Disinfectants and Implications for Infection Control. Front. Microbiol. 2018, 9, 726. [Google Scholar] [CrossRef] [PubMed]
- New Guidance on Environmental Control of Candida auris with Antimicrobial Pesticides. 2017. Available online: https://www.epa.gov/pesticides/new-guidance-environmental-control-candida-auris-antimicrobial-pesticides (accessed on 22 October 2019).
- Selected EPA-registered Disinfectants. 2018. Available online: https://www.epa.gov/pesticide-registration/selected-epa-registered-disinfectants (accessed on 22 October 2019).
- Cadnum, J.L.; Shaikh, A.A.; Piedrahita, C.T.; Sankar, T.; Jencson, A.L.; Larkin, E.L.; Ghannoum, M.A.; Donskey, C.J. Effectiveness of Disinfectants Against Candida auris and Other Candida Species. Infect. Control Hosp. Epidemiol. 2017, 38, 1240–1243. [Google Scholar] [CrossRef] [Green Version]
- Bleach Wipes Kill Candida auris. 2019. Available online: https://www.mcknights.com/news/products/bleach-wipes-kill-candida-auris/ (accessed on 22 October 2019).
- EPA Approves Diversey Claim that Oxiver 1 is Effective Against C. auris. 2019. Available online: https://www.hpnonline.com/evs-facility-services/article/21086724/epa-approves-diversey-claim-that-oxiver-1-is-effective-against-c-auris (accessed on 22 October 2019).
- Rutala, W.A.; Kanamori, H.; Gergen, M.F.; Sickbert-Bennett, E.E.; Weber, D.J. Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities. Infect. Control Hosp. Epidemiol. 2019, 40, 380–382. [Google Scholar] [CrossRef]
- Weber, D.J.; Sickbert-Bennett, E.E.; Kanamori, H.; Rutala, W.A. New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility. Am. J. Infect. Control. 2019, 47, A29–A38. [Google Scholar] [CrossRef] [Green Version]
- Environmental Infection Control Guidelines. 2015. Available online: https://www.cdc.gov/infectioncontrol/guidelines/environmental/index.html (accessed on 22 October 2019).
- Kenters, N.; Kiernan, M.; Chowdhary, A.; Denning, D.W.; Peman, J.; Saris, K.; Schelenz, S.; Tartari, E.; Widmer, A.; Meis, J.F.; et al. Control of Candida auris in healthcare institutions: Outcome of an International Society for Antimicrobial Chemotherapy expert meeting. Int. J. Antimicrob. Agents. 2019, 54, 400–406. [Google Scholar] [CrossRef]
- Treatment and Management of Infections and Colonization: Recommendations for Treatment of Candida auris Infections. 2019. Available online: https://www.cdc.gov/fungal/candida-auris/c-auris-treatment.html (accessed on 22 October 2019).
- Pappas, P.G.; Kauffman, C.A.; Andes, D.R.; Clancy, C.J.; Marr, K.A.; Ostrosky-Zeichner, L.; Reboli, A.C.; Schuster, M.G.; Vazquez, J.A.; Walsh, T.J.; et al. Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America. Clin. Infect. Dis. 2016, 62, e1–e50. [Google Scholar] [CrossRef] [Green Version]
- Schelenz, S.; Hagen, F.; Rhodes, J.L.; Abdolrasouli, A.; Chowdhary, A.; Hall, A.; Ryan, L.; Shackleton, J.; Trimlett, R.; Meis, J.F.; et al. First hospital outbreak of the globally emerging Candida auris in a European hospital. Antimicrob. Resist. Infect. Control 2016, 5, 35. [Google Scholar] [CrossRef] [Green Version]
Identification Method | Organism C. auris Can be Misidentified as |
---|---|
VITEK 2 YST * |
|
API 20C |
|
BD Phoenix yeast identification system |
|
MicroScan |
|
RapID Yeast Plus |
|
Check databases of identification methods used, as capacity to detect C. auris may differ by database. * There have been reports of C. auris being misidentified as Candida lusitaniae and Candida famata on VITEK 2. A confirmatory test such as cornmeal agar may be warranted for these species. | |
|
Identification of cases:
|
Hand hygiene
|
Transmission-based precautions Place all patients infected or colonized with C. auris in acute care hospitals or long-term acute care hospitals on contact precautions. In nursing homes, consider placing residents with C. auris on less restrictive precautions (i.e., CDC’s enhanced barrier precautions), unless they have uncontrolled secretions or excretions or there is ongoing transmission on the unit or facility. Otherwise, use contact precautions.
|
Environmental cleaning
|
Patient decolonization
|
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Caceres, D.H.; Forsberg, K.; Welsh, R.M.; Sexton, D.J.; Lockhart, S.R.; Jackson, B.R.; Chiller, T. Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings. J. Fungi 2019, 5, 111. https://doi.org/10.3390/jof5040111
Caceres DH, Forsberg K, Welsh RM, Sexton DJ, Lockhart SR, Jackson BR, Chiller T. Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings. Journal of Fungi. 2019; 5(4):111. https://doi.org/10.3390/jof5040111
Chicago/Turabian StyleCaceres, Diego H., Kaitlin Forsberg, Rory M. Welsh, David Joseph Sexton, Shawn R. Lockhart, Brendan R. Jackson, and Tom Chiller. 2019. "Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings" Journal of Fungi 5, no. 4: 111. https://doi.org/10.3390/jof5040111
APA StyleCaceres, D. H., Forsberg, K., Welsh, R. M., Sexton, D. J., Lockhart, S. R., Jackson, B. R., & Chiller, T. (2019). Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings. Journal of Fungi, 5(4), 111. https://doi.org/10.3390/jof5040111